These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19787254)

  • 1. Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
    Int J Oncol; 2009 Nov; 35(5):1005-14. PubMed ID: 19787254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Sakamoto A
    Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
    Int J Oncol; 2010 Jan; 36(1):161-70. PubMed ID: 19956845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.
    Suzuki H; Murata K; Gotoh T; Kusano M; Okano H; Oyamada T; Yasuda Y; Imamura M; Kudo M; Mizokami M; Sakamoto A
    J Gastroenterol; 2011 Oct; 46(10):1219-29. PubMed ID: 21744129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
    Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
    J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
    Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades.
    Murata K; Saito A; Katagiri S; Ariizumi S; Nakano M; Yamamoto M
    J Med Ultrason (2001); 2018 Apr; 45(2):223-229. PubMed ID: 28828695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
    Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
    J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-gamma-carboxy prothrombin (DCP) antagonizes the effects of gefitinib on human hepatocellular carcinoma cells.
    Cui SX; Zhang YS; Chu JH; Song ZY; Qu XJ
    Cell Physiol Biochem; 2015; 35(1):201-12. PubMed ID: 25591763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.
    Gao FJ; Cui SX; Chen MH; Cheng YN; Sun LR; Ward SG; Kokudo N; Tang W; Qu XJ
    Life Sci; 2008 Dec; 83(23-24):815-20. PubMed ID: 18976674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma.
    Yuan LW; Tang W; Kokudo N; Sugawara Y; Karako H; Hasegawa K; Aoki T; Kyoden Y; Deli G; Li YG; Makuuchi M
    Oncol Rep; 2004 Aug; 12(2):269-73. PubMed ID: 15254687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
    Weitz IC; Liebman HA
    Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.
    Taniguchi T; Kishi K; Nakagawa T; Tanaka H; Tanaka T; Tomonari T; Okamoto K; Sogabe M; Miyamoto H; Okahisa T; Muguruma N; Kajimoto M; Sagawa I; Takayama T
    Digestion; 2017; 95(3):242-251. PubMed ID: 28384634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.
    Bertino G; Ardiri AM; Calvagno GS; Bertino N; Boemi PM
    Drug News Perspect; 2010 Oct; 23(8):498-508. PubMed ID: 21031166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.
    Cui SX; Yu XF; Qu XJ
    Cancer Invest; 2016 Oct; 34(9):459-464. PubMed ID: 27673353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.
    Ueda N; Shiraha H; Fujikawa T; Takaoka N; Nakanishi Y; Suzuki M; Matsuo N; Tanaka S; Nishina S; Uemura M; Takaki A; Shiratori Y; Yamamoto K
    Mol Oncol; 2008 Oct; 2(3):241-9. PubMed ID: 19383345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Fujikawa T; Shiraha H; Yamamoto K
    Acta Med Okayama; 2009 Dec; 63(6):299-304. PubMed ID: 20035286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
    Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
    Am J Gastroenterol; 1990 Sep; 85(9):1149-54. PubMed ID: 1697141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.